The outcome of different limb-saving treatment modalities for pelvic @entity242 is controversial. The oncological and functional results after 11 external and 10 internal hemipelvectomies and the consequences of limb-salvage treatment were studied in 21 consecutive @entity1 with primary bone (19 @entity1 ) or soft tissue @entity242 (two @entity1 ) of the pelvic girdle. Following external hemipelvectomy, 10 @entity1 (91%) died after a median follow-up of 1.6 years (range: 0.3-7.1). Isolated local recurrences occurred in three @entity1 (27%), with concomitant distant failure in one (9%), while isolated distant failure occurred in six @entity1 (55%). The rate of flap @entity39 and wound @entity281 following external hemipelvectomy were both 25%. Following internal hemipelvectomy, nine @entity1 (90%) were alive without evidence of disease after a median follow-up of 6.6 years (range: 2.3-16.0). Concomitant local and distant failures were found in one @entity1 (10%). Reconstruction-related complications necessitated revisional procedures in five of seven @entity1 (72%), leading to external hemipelvectomy in one. @entity1 with a locally advanced pelvic @entity242 who are unable to undergo an internal hemipelvectomy have a worse prognosis than @entity1 who undergo an internal hemipelvectomy. An internal hemipelvectomy is not attended by an increased risk of local failure, but is by long-term local complications, requiring extensive surgical procedures.

External and internal hemipelvectomy for XXXX of the pelvic girdle: consequences of limb-salvage treatment.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity281 :: ('MESH:D007239', 'Disease') :: ['infection'] @entity242 :: ('MESH:D012509', 'Disease') :: ['sarcoma', 'girdle sarcoma'] @entity39 :: ('MESH:D009336', 'Disease') :: ['necrosis']
@entity242 :: (MESH:D012509,Disease) :: ['sarcomas']
